|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Operating activities: | |||||
| Net loss | |||||
| Adjustments to reconcile net loss to net cash provided by (used in) operating activities: | |||||
| Depreciation and amortization | |||||
| Amortization of acquired intangible assets | |||||
| Expensed in-process research and development | |||||
| Non-cash lease expense | |||||
| Stock-based compensation | |||||
| Amortization of premiums and accretion of purchase discounts on investment securities | |||||
| Change in fair value of warrants and preferred stock of related party equity investment | |||||
| Foreign exchange adjustment | |||||
| Amortization of debt discount and issuance cost | |||||
| Provision for credit losses | |||||
| Non-cash interest expense | |||||
| Non-cash expense recovery | |||||
| Changes in operating assets and liabilities: | |||||
| Accounts receivable | |||||
| Inventory | |||||
| Operating lease right-of-use assets | |||||
| Prepaid expenses and other assets | |||||
| Accounts payable | |||||
| Accrued compensation | |||||
| Deferred tax liability | |||||
| Operating lease liabilities | |||||
| Other accrued liabilities | |||||
| Deferred revenue | |||||
| Net cash provided by (used in) operating activities | |||||
| Investing activities: | |||||
| Purchases of investments | |||||
| Proceeds from sale of investments | |||||
| Proceeds from maturity of investments | |||||
| Purchases of property and equipment, net | |||||
| Cash paid for acquisition of intangible assets | |||||
| Purchase of intangible assets, net | |||||
| Investment in related party | |||||
| Cash paid for business combination, net | |||||
| Net cash (used in) provided by investing activities | |||||
| Financing activities: | |||||
| Proceeds from exercise of stock options | |||||
| Proceeds from issuance of common stock under employee stock purchase plan | |||||
| Proceeds from public offering, net of issuance cost | |||||
| Stock issuance costs | |||||
| Cash redemption on Convertible Note | |||||
| Net cash provided by financing activities | |||||
| Net change in cash, cash equivalents and restricted cash | |||||
| Beginning cash, cash equivalents and restricted cash | |||||
| Ending cash, cash equivalents and restricted cash | |||||
| Supplemental disclosure of cash flow information: | |||||
| Cash paid for income taxes, net | |||||
| Cash paid for interest | |||||
| Non-cash activities: | |||||
| Purchases of property and equipment in accounts payable and accruals | |||||
| Acquisition of warrants | |||||
| Amounts accrued for acquisition of intangible assets | |||||
| Contingent consideration for business combination | |||||
| Issuance of common stock for business combination | |||||
| Issuance of common stock for IPR&D milestone | |||||
| Issuance of common stock for bonuses | |||||
| Stock-based compensation included in capitalized software development costs | |||||
| Debt and interest converted into equity | |||||
Loading...